consensus estimates,0.345757
Analyst Ratings.Net reports,-0.258863
RBC Capital,0.4185
stock,-0.0877255
InvestorPlace Broker Center,0.555736
End-stage lung disease,-0.538429
12-month high,-0.288269
viral infectious diseases,-0.496163
key therapeutic products,0.329454
Standpoint Research,0.201002
sell rating,0.460939
personal trading style,0.598412
investment analyst,0.460939
Leerink Swann,0.332515
target price,-0.0675966
research note,0.358123
United Therapeutics Corporation,0.246832
United Therapeutics Co.,0.54296
average price,-0.277062
shares,0.0337116
concise daily summary,0.445115
quarterly revenue,-0.403041
Ex-Vivo Lung Perfusion,-0.519184
Pulmonary Arterial Hypertension,-0.299877
stock broker,0.245696
United Therapeutics,0.0377187
biotechnology company,0.246832
quarter,-0.334203
